Menu
Expand your knowledge.
Liver health experts Dr. Naim Alkhouri and patient advocate Michael Betel share highlights and key insights from the world’s leading forum on liver disease!
Naim Alkhouri, M.D., FAASLD, is the Chief Medical Officer (CMO), Chief of Transplant Hepatology, and Director of the Fatty Liver Program at Arizona Liver Health (ALH) in Phoenix, AZ. Dr. Alkhouri is a key opinion leader in the field of NASH therapeutics and an advisor/consultant to many pharmaceutical and biomarker development companies. He is Principal Investigator on several multicenter global NASH trials and a member of the AASLD NASH Special Interest Group (NASH SIG).
Michael Betel is the President and Founder of the Fatty Liver Alliance, a charity focused on the early detection, prevention, and treatment of NAFLD and NASH. He has been a leader in the area of liver disease, in both commercial and not-for-profit organizations for over 25 years, as a Director at Hoffmann-La Roche and Canadian Blood Services, and as a sales and marketing leader at Schering-Plough. He was a Director on the board of a national liver-focused health charity for 9 years. He is currently the Chair of the Global Liver Institute’s Liver Action Network, which includes 12 community liver advocacy organizations.
